130 related articles for article (PubMed ID: 37421290)
41. Screening and identification of CNIH4 gene associated with cell proliferation in gastric cancer based on a large-scale CRISPR-Cas9 screening database DepMap.
Zhang H; Lin Y; Zhuang M; Zhu L; Dai Y; Lin M
Gene; 2023 Jan; 850():146961. PubMed ID: 36220450
[TBL] [Abstract][Full Text] [Related]
42. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
[TBL] [Abstract][Full Text] [Related]
43. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract][Full Text] [Related]
44. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape.
Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833
[TBL] [Abstract][Full Text] [Related]
45. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
[TBL] [Abstract][Full Text] [Related]
46. Identification of ATG7 as a Regulator of Proferroptosis and Oxidative Stress in Osteosarcoma.
Jiang R; He S; Gong H; Wang Y; Wei W; Chen J; Hu J; Ye C; LiuHuang S; Jin S; Wei H; Xu W; Xiao J
Oxid Med Cell Longev; 2022; 2022():8441676. PubMed ID: 36254233
[TBL] [Abstract][Full Text] [Related]
47. A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma.
Zheng Y; Xu J; Lin J; Lin Y
Comput Math Methods Med; 2022; 2022():8003525. PubMed ID: 35844445
[TBL] [Abstract][Full Text] [Related]
48. Machine learning and experimental validation to construct a metastasis-related gene signature and ceRNA network for predicting osteosarcoma prognosis.
Liao Y; Liu Q; Xiao C; Zhou J
J Orthop Surg Res; 2022 Dec; 17(1):516. PubMed ID: 36457129
[TBL] [Abstract][Full Text] [Related]
49. Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells.
Liao Y; Chen L; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z
Oncotarget; 2017 May; 8(18):30276-30287. PubMed ID: 28415820
[TBL] [Abstract][Full Text] [Related]
50. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
Front Immunol; 2022; 13():916800. PubMed ID: 35860239
[TBL] [Abstract][Full Text] [Related]
51. Artificial neural network-based gene screening and immune cell infiltration analysis of osteosarcoma feature.
Shi S; Guo Y; Wang Q; Huang Y
J Gene Med; 2024 Jan; 26(1):e3622. PubMed ID: 37964329
[TBL] [Abstract][Full Text] [Related]
52. Identification of necroptosis-related gene TRAF5 as potential target of diagnosing atherosclerosis and assessing its stability.
Peng Z; Wang K; Wang S; Wu R; Yao C
BMC Med Genomics; 2023 Jun; 16(1):139. PubMed ID: 37330462
[TBL] [Abstract][Full Text] [Related]
53. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
[TBL] [Abstract][Full Text] [Related]
56. Predicting prognosis and immune status in sarcomas by identifying necroptosis-related lncRNAs.
Wang Z; He A; Lu Z; Xu W; Wu G; Peng T
Aging (Albany NY); 2024 Jan; 16(1):493-517. PubMed ID: 38194709
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
Xu F; Yan J; Peng Z; Liu J; Li Z
Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
[TBL] [Abstract][Full Text] [Related]
58. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
59. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma.
Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J
Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472
[TBL] [Abstract][Full Text] [Related]
60. Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
Feng Y; Sassi S; Shen JK; Yang X; Gao Y; Osaka E; Zhang J; Yang S; Yang C; Mankin HJ; Hornicek FJ; Duan Z
J Orthop Res; 2015 Feb; 33(2):199-207. PubMed ID: 25348612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
